On September 23, 2021, Sonim Technologies, Inc. (the “Company”) entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Sales Agent”) to sell shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), having an aggregate offering price of up to $41,636,612 (the “Shares”), from time to time, through an “at the market offering” program (the “ATM Program”).
Pursuant to the terms of the Sales Agreement, sales of the Shares under the ATM Program, if any, will be made through the Sales Agent acting as sales agent or directly to the Sales Agent acting as principal, by any method that is deemed to be an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”).
The offering of Shares under the ATM Program pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of the maximum aggregate amount of the Shares subject to the Sales Agreement, or (ii) termination of such Sales Agreement as permitted therein.
Under the terms of the Sales Agreement, the Company will pay the Sales Agent a commission equal to 3.0% of the gross proceeds from each sale of Common Stock sold through it under the Sales Agreement. The Company has also provided the Sales Agent with customary indemnification rights and has agreed to pay certain expenses incurred by the Sales Agent in connection with the offering.
The Company intends to use the net proceeds to fund ongoing operations. Pending such use, the Company may invest the net proceeds from the Shares sold under the ATM Program in short-term interest-bearing accounts, securities or similar investments.
The foregoing description of the Sales Agreement is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The Shares sold under the ATM Program will be issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-254440), filed by the Company with the SEC on March 18, 2021 and declared effective by the SEC on April 12, 2021 (the “Base Prospectus”) and the prospectus supplement filed by the Company with the SEC pursuant to Rule 424(b) under the Securities on September 24, 2021 (the “Prospectus Supplement”). This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of Shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
The Company is filing as Exhibit 5.1 to this Current Report on Form 8-K an opinion of O’Melveny & Myers LLP regarding certain matters of Delaware law, including the validity of the Shares to be sold under the ATM Program.
Item 9.01 | Financial Statements and Exhibits. |